FDA Brief

Company record

QuVa Pharma, Inc.

1 FDA warning letter since 2023 and 1 recall in the last 12 months.

Get an email the day FDA posts anything new about QuVa Pharma, Inc..

Warning letters

  1. QuVa Pharma, Inc.

    Compounding Pharmacy/Adulterated Drug Products

Recalls

ReportedClassFirmProduct and reason
Jul 15 Class II QuVa Pharma, Inc.
Drug
Methohexital Sodium, 100 mg/10 mL (10 mg/mL), Total Volume: 10 mL, Rx only, Compounded drug, QuVa Pharma, 1075 W Park One Dr, Suite 100, Sugar Land, TX 77478, Product code: 70092-1310-46.
Failed Impurities/Degradation Specifications